DICE Therapeutics Inc - Company Profile
Powered by 
All the data and insights you need on DICE Therapeutics Inc in one report.
$295
- Save hours of research time and resources with
our up-to-date DICE Therapeutics Inc Strategy Report
- Understand DICE Therapeutics Inc position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
DICE Therapeutics Inc (DICE Therapeutics), formerly DiCE Molecules Holdings LLC, is a pre-clinical stage biopharmaceutical company that develops drugs for the treatment of immunological and chronic diseases. The company is investigating its lead product candidate IL-17 (interleukin 17), an immune-cell-derived cytokine to treat psoriasis and other IL-17 mediated chronic immune disorders and other indications. It is also evaluating drug candidates for the treatment of inflammatory bowel disease, fibrosis and other immune-oncology disorders. The company harnesses its proprietary DELSCAPE platform technology to identify selective oral small molecule antagonists to modulate protein-protein interactions (PPI) targets. DICE Therapeutics is headquartered in South San Francisco, California, the US.
Headquarters
United States of America
Address
400 East Jamie Court, Suite 300, South San Francisco, California, 94080
Website
www.dicetherapeutics.com
Telephone
1 650 5661402
No of Employees
81
Industry
Pharmaceuticals and Healthcare
DICE Therapeutics Inc premium industry data and analytics
Products and Services
| Products |
|---|
| Pipeline |
| IL-17: |
| Psoriasis and other IL-17 Mediated Chronic Immunology Indications |
| XYZ |
| XYZ |
| XYZ |
Competitor Comparison
| Key Parameters | DICE Therapeutics Inc | Novartis AG | Eli Lilly and Co | Amgen Inc | Bausch Health Companies Inc |
|---|---|---|---|---|---|
| Headquarters | United States of America | Switzerland | United States of America | United States of America | Canada |
| City | South San Francisco | Basel | Indianapolis | Thousand Oaks | Laval |
| State/Province | California | - | Indiana | California | Quebec |
| No. of Employees | 81 | 76,057 | 43,000 | 26,700 | 20,270 |
| Entity Type | Private | Public | Public | Public | Public |
Executives
| Name | Position | Board | Since | Age |
|---|---|---|---|---|
| Richard Scheller, PhD | Chairman | Executive Board | 2015 | 69 |
| J. Kevin Judice, PhD | Director; Chief Executive Officer | Executive Board | 2013 | 60 |
| Scott Robertson | Chief Business Officer; Chief Financial Officer | Senior Management | 2021 | 44 |
| Timothy Lu, MD, PhD | Chief Medical Officer | Senior Management | 2020 | 49 |
| John Jacobsen, PhD | Chief Scientific Officer | Senior Management | 2021 | 55 |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer